Stock listing
NASDAQ:AKRX Akorn Inc Stock
Follow Akorn Inc into a list and get an email when it puts out news.
Delisted NASDAQ:AKRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AKRX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Akorn Inc on 6ix
- Decks
- 9 decks · latest Sep 9, 2020
Where Akorn Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AKRX · This page · Delisted | NASDAQ | United States | USD |
| OTC:AKRXQ · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (September 2020) | Corporate update | 16 slides | Sep 9, 2020 |
| Debt Investor Presentation (August 2020) | Debt investors | 15 slides | Aug 14, 2020 |
| Corporate Update (July 2020) | Corporate update | 21 slides | Jul 2, 2020 |
| Investor Presentation (April 2020) | Investor deck | 66 slides | Apr 22, 2020 |
| Investor Presentation (November 2019) | Investor deck | 21 slides | Nov 12, 2019 |
| Investor Presentation (September 2019) | Investor deck | 21 slides | Sep 10, 2019 |
| Investor Presentation (September 2014) | Investor deck | 22 slides | Sep 12, 2014 |
| Merger or Acquisition (May 2014) | Merger or acquisition | 9 slides | May 12, 2014 |
| Merger or Acquisition (August 2013) | Merger or acquisition | 13 slides | Aug 27, 2013 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adrienne L. Graves Other companies: Opus Genetics, Inc. (Director · Since at least Oct 22, 2024); Harrow, Inc. (Member, Board of Directors, Independent Director · Since at least Jan 26, 2024); Ocular Therapeutix, Inc. (Director · Since at least Jul 10, 2023); IVERIC bio Inc (Director · Dec 12, 2018 – Jul 11, 2023 · Past); TearLab Corporation (TEAR) (Director · Jun 24, 2016 – Jun 24, 2016 · Past) | Director · Jul 1, 2016 – May 9, 2019 · Past |
| Terry Allison Rappuhn Other companies: HealthStream, Inc. (Director · Since at least Jan 6, 2022); Quorum Health Corporation (Director · Sep 27, 2017 – May 31, 2019 · Past); AGA Medical Holdings Inc (Director · Oct 20, 2009 – Nov 18, 2010 · Past) | Director · Apr 20, 2015 – May 13, 2019 · Past |
| John N Kapoor Other companies: INSYS Therapeutics Inc (Director · May 2, 2013 – Aug 11, 2017 · Past); Sciele Pharma Inc (Director · Dec 31, 2005 – Nov 1, 2006 · Past) | Director · Jan 13, 2006 – May 11, 2017 · Past |
| Kenneth Abramowitz Other companies: Ivivi Technologies Inc (Director · Mar 10, 2009 – Mar 31, 2009 · Past); Power Medical Interventions Inc (Director · Oct 25, 2007 – Dec 31, 2007 · Past) | Director · May 21, 2010 – May 9, 2019 · Past |
| Arthur Przybyl Other companies: ANI Pharmaceuticals, Inc. (President and CEO, Director · Jun 19, 2013 – Apr 6, 2020 · Past) | President, CEO, Director · Apr 20, 2007 – Dec 31, 2008 · Past |
| Brian Tambi Other companies: INSYS Therapeutics Inc (Director · May 2, 2013 – Feb 21, 2018 · Past) | Director · Jun 22, 2009 – May 9, 2019 · Past |
| Douglas Boothe Other companies: Impax Laboratories Inc (President, Generics Division · Aug 1, 2016 – May 4, 2018 · Past) | President and CEO, Director · Jan 1, 2019 – Jan 8, 2020 · Past |
| Jeffrey Whitnell Other companies: Elite Pharmaceuticals, Inc. (Director · Since at least Feb 3, 2011) | Interim CEO/CFO, Director · Mar 31, 2006 – Apr 20, 2009 · Past |
| Jerry N Ellis Other companies: Sciele Pharma Inc (Director · Jun 15, 2006 – May 23, 2008 · Past) | Director · May 23, 2006 – May 21, 2010 · Past |
| Jerry Treppel Other companies: Elite Pharmaceuticals, Inc. (Chairman of Board, Director · Oct 28, 2008 – Nov 13, 2015 · Past) | Director · Jan 13, 2006 – Aug 7, 2009 · Past |
All 27 people
| Person | Seat |
|---|---|
| Randall E Pollard Other companies: Harrow, Inc. (CHIEF ACCOUNTING OFFICER · Since at least Sep 1, 2025) | SVP, Finance & CAO · Aug 3, 2015 – Aug 28, 2020 · Past |
| Steven J Meyer Other companies: INSYS Therapeutics Inc (Director · May 14, 2013 – Apr 23, 2019 · Past) | Director · Jun 22, 2009 – Mar 2, 2020 · Past |
| Thomas Gregory Moore Other companies: Avenue Therapeutics, Inc. (Director · Apr 30, 2019 – Apr 30, 2019 · Past) | Director · Jan 24, 2019 – Jan 24, 2019 · Past |
| Abu S Alam | Sr. VP, New Bus Development · Jan 13, 2006 – Dec 18, 2007 · Past |
| Alan D Weinstein | Director · Sep 12, 2012 – May 31, 2019 · Past |
| Bruce Kutinsky | Chief Operating Officer · Mar 28, 2016 – Apr 19, 2018 · Past |
| Christopher Young | EVP, Global Operations · Jan 24, 2019 – Mar 13, 2020 · Past |
| Erislandy Dorado-Boladeres | EVP, Global Quality · Mar 25, 2019 – Mar 25, 2020 · Past |
| John R Sabat | Sr. V.P. National Accts Sales · Jan 13, 2006 – Dec 8, 2014 · Past |
| John W Stern | VP, Hospital & Contract Sales · Mar 31, 2006 – Aug 16, 2007 · Past |
| Jonathan Kafer | EVP & Chief Commercial Officer · May 8, 2016 – Aug 28, 2020 · Past |
| Joseph Bonaccorsi | EVP Gen Counsel & Secretary · May 6, 2009 – Aug 28, 2020 · Past |
| Rajat Rai | Chief Executive Officer · Jun 8, 2009 – Sep 5, 2018 · Past |
| Randall J Wall | Director · May 21, 2010 – May 21, 2010 · Past |
| Ronald M Johnson | Director · May 23, 2006 – May 9, 2019 · Past |
| Steven Lichter | EVP, Pharmaceutical Operations · Feb 16, 2015 – Apr 19, 2018 · Past |
| Timothy A Dick | Chief Financial Officer · Jun 12, 2009 – Feb 1, 2015 · Past |
Log in to ask 6ix AI your own questions about Akorn Inc.